miRNA-125a-5p has been demonstrated as an independent prognostic factor in gastric cancer and inhibiting gastric cancer development [18], through targeting oncogenes such as vascular endothelial growth factor A [19] and E2F transcription factor 3 [20]. This evidence concerns the gene E2F3 and gastric cancer.